Enoximone echocardiography for predicting recovery of left ventricular dysfunction after revascularization : A novel test for detecting myocardial viability

• Published in: Circulation (New York, N.Y.) Vol. 101; no. 11; pp. 1255 - 1260
• Main Authors: CHUNZENG LU, CARLINO, M, FRAGASSO, G, MAISANO, F, MARGONATO, A, CAPPELLETTI, A, CHIERCHIA, S. L
• Format: Journal Article
• Language: English
• Published: Hagerstown, MD Lippincott Williams & Wilkins 21.03.2000; American Heart Association, Inc
• Subjects: Adult; Aged; Biological and medical sciences; Cardiology. Vascular system; Cardiotonic Agents; Coronary heart disease; Dobutamine; Echocardiography; Enoximone; Heart; Heart - physiopathology; Humans; Male; Medical sciences; Middle Aged; Myocardial Contraction; Myocardial Revascularization; Predictive Value of Tests; Prognosis; Recovery of Function; Sensitivity and Specificity; Tissue Survival; Ventricular Dysfunction, Left - diagnostic imaging; Ventricular Dysfunction, Left - physiopathology; Ventricular Dysfunction, Left - surgery; Ventricular Function, Left; Sonography; Human; Pharmacologic test; Cardiotonic agent; Echocardiography; Prognosis; Cardiovascular disease; Coronary heart disease; Left ventricle; Chronic; Dysfunction; Enoximone; Myocardium; Viability

The possibility that enoximone, a nonglycoside, noncatechol, positive inotropic agent, in combination with 2-dimensional echocardiography may predict recovery of myocardial dysfunction after revascularization has not been yet evaluated. Forty-five patients with chronic coronary artery disease and le...